Arrowhead to Present at Rodman & Renshaw
Annual Global Investment Conference
Rodman & Renshaw Annual Global Investment Conference NYC
September 09, 2010 10:15 AM Eastern Daylight Time
PASADENA, Calif.--(EON: Enhanced Online News)--Arrowhead Research Corporation (NASDAQ:
ARWR) today announced that Dr. Christopher Anzalone, Chief Executive Officer, will be presenting at the Rodman
& Renshaw Annual Global Investment Conference at 5:45 p.m. EDT on Tuesday, September 14, 2010, at the
Palace Hotel in New York, NY. Dr. Anzalone will be discussing the Company and its increased focus on its
nanomedicine portfolio, including clinical results.
Professional investors attending the conference are encouraged to schedule a one-on-one meeting with management
by emailing email@example.com.
The presentation will be webcast live and is available for viewing at Arrowhead’s website at
www.arrowheadresearch.com under the “Investor Relations” section by selecting the “Presentations and Events,”
tab. An archive of the presentation will be available for 90 days following the conference.
Arrowhead recommends registering at least 10 minutes prior to the start of the presentation to ensure timely access.
About Arrowhead Research Corporation
Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology
company commercializing new technologies in the areas of life sciences and electronics. Arrowhead is seeking to
build value for shareholders through the progress of its subsidiaries and investments. Currently, Arrowhead is
focused primarily on its two majority owned subsidiaries; Unidym, a leader in carbon nanotube technology for
electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology. Arrowhead
also has minority investments in two privately held nanobiotech companies.
The Piacente Group